Product TypeCompany Earnings Update Product TypeCompany Earnings Update | June 30, 2017 Register for Free Access Walgreens Boots Alliance (WBA) Fiscal 3Q17 Results: Beats and Raises Guidance, Announces New Agreement with Rite AidWalgreens Boots Alliance reported fiscal 3Q17 adjusted EPS of $1.33, above the $1.30 consensus estimate. Revenues were $30.1 billion, up 2.1% year over year and above the $29.7 billion consensus estimate. Sales increased by 5.0% on a constant-currency basis in the quarter.Read More
Product TypeEvent Coverage Product TypeEvent Coverage | December 19, 2016 Register for Free Access Notes from CVS Health 2016 Annual Analyst Day: Driving More Affordable, Accessible and Effective CareCVS Health held its annual analyst day on December 15 in New York City. The main topics of the meeting were the company’s long-term growth drivers and its three main objectives: to make care more affordable, more accessible and more effective.Read More
Product TypeFlash Report Product TypeFlash Report | November 9, 2016 Register for Free Access CVS Pharmacy [CVS] 3Q16 Results: Mixed Quarter; Company Reduces and Narrows Guidance RangeCVS reported 3Q16 adjusted EPS of $1.64, up 28.0% year over year and beating the $1.57 consensus estimate. Revenues were $44.6 billion, up 15.5% year over year, missing the $45.3 billion consensus estimate.Read More
Product TypeFlash Report Product TypeFlash Report | October 7, 2016 Register for Free Access Walgreens Boots Alliance Displaces CVS from Tricare Pharmacy NetworkWalgreens Boots Alliance (WBA) will replace CVS as the in-network pharmacy for Tricare, the healthcare program of the US Department of Defense Military Health System.Read More
Product TypeFlash Report Product TypeFlash Report | August 2, 2016 Register for Free Access CVS Pharmacy (CVS) 2Q16 Results: Mixed Quarter, but Company Raises GuidanceCVS reported 2Q16 adjusted EPS of $1.32, up 8.3% year over year and ahead of guidance of $1.28–$1.31, beating the consensus estimate by two cents. The company reported revenues of $43.7 billion, up 17.6% year over year but missing the $44.3 billion consensus estimate.Read More
Product TypeFlash Report Product TypeFlash Report | April 5, 2016 Register for Free Access Walgreens Boots Alliance (WBA) 2Q16 Results: In-Line Results Driven by Strong Pharmacy BusinessWalgreens Boots Alliance reported fiscal 2Q16 revenues of $30.2 billion, up 13.6% from the year-ago period and slightly below the consensus estimate of $30.7 billion. Adjusted EPS was $1.31, up 10.8% year over year and slightly above the consensus estimate of $1.28.Read More
Product TypeFlash Report Product TypeFlash Report | February 10, 2016 Register for Free Access CVS Health (CVS) 4Q15 Results: Strong Growth Aided by AcquisitionsCVS Health reported that 4Q15 net sales rose by 11.0% year over year, to $41.1 billion, slightly above the consensus estimate of $41.0 billion. Read More
Product TypeCompany Earnings Update Product TypeCompany Earnings Update | December 16, 2015 Register for Free Access CVS Pharmacy Analyst Day TakeawaysCVS Health held an Analyst Day in New York today. In attendance from the company were President and CEO Larry Merlo, EVP and CFO Dave Denton, President of CVS/caremark Jon Roberts, EVP of CVS/Specialty Pharmacy Alan Lotvin, President of CVS/pharmacy Helena Foulkes and President of Omnicare Rocky Kraft.Read More
Product TypeFlash Report Product TypeFlash Report | October 28, 2015 Register for Free Access Walgreens to Acquire Rite Aid in $17.2 Billion DealTuesday, Oct. 27, after the market close, Walgreens Boots Alliance announced an agreement to acquire smaller drugstore chain Rite Aid for $9.4 billion in cash, offering $9 per share in cash, which represents a 48% premium to Rite Aid’s closing price of $6.08 on Monday.Including debt, the deal is valued at $17.2 billion, the company said.Read More
